retatrutide drug Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide for weight loss: Study

Once-daily oral semaglutide Semaglutide is available as an oral tablet under the brand name Rybelsus to help people with type-2 diabetes achieve adequate glycemic control

Below is a comprehensive timeline based on published data from the STEP trials for semaglutide, the SURMOUNT trials for tirzepatide, and thousands of documented patient experiences

Conversely, peptides developed solely on the basis of biomarker changes without clear clinical relevance may face reimbursement challenges regardless of regulatory approval (Ciani et al., 2023)

Kauser S, Schallreuter KU, Thody AJ, Gummer C, Tobin DJ

doi:10.1210/jc.2003-031907

From $149/mo Wegovy pill self-pay Providers 5 Reviewed in 2026 Covered 67% of employer plans We may earn a commission when you click links to providers